| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | ||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
Eikon Therapeutics, Inc. [ EIKN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/04/2026 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 02/04/2026 | C(1) | 1,340,878 | A | $0.00 | 1,340,878 | I | See Footnote(2) | ||
| Common Stock | 02/04/2026 | C(1) | 335,521 | A | $0.00 | 1,676,399 | I | See Footnote(2) | ||
| Common Stock | 02/04/2026 | C(1) | 37,855 | A | $0.00 | 1,714,254 | I | See Footnote(2) | ||
| Common Stock | 02/04/2026 | C(1) | 229,428 | A | $0.00 | 1,943,682 | I | See Footnote(2) | ||
| Common Stock | 02/04/2026 | C(1) | 697,885 | A | $0.00 | 697,885 | I | See Footnote(3) | ||
| Common Stock | 02/04/2026 | C(1) | 37,855 | A | $0.00 | 735,740 | I | See Footnote(3) | ||
| Common Stock | 02/04/2026 | C(1) | 1,626 | A | $0.00 | 737,366 | I | See Footnote(3) | ||
| Common Stock | 02/04/2026 | C(1) | 67,207 | A | $0.00 | 804,573 | I | See Footnote(3) | ||
| Common Stock | 02/04/2026 | C(1) | 458,855 | A | $0.00 | 1,263,428 | I | See Footnote(3) | ||
| Common Stock | 02/04/2026 | C(1) | 348,942 | A | $0.00 | 348,942 | I | See Footnote(4) | ||
| Common Stock | 02/04/2026 | C(1) | 37,855 | A | $0.00 | 386,797 | I | See Footnote(4) | ||
| Common Stock | 02/04/2026 | C(1) | 922 | A | $0.00 | 387,719 | I | See Footnote(4) | ||
| Common Stock | 02/04/2026 | C(1) | 38,133 | A | $0.00 | 425,852 | I | See Footnote(4) | ||
| Common Stock | 02/04/2026 | C(1) | 408,725 | A | $0.00 | 408,725 | I | See Footnote(5) | ||
| Common Stock | 02/04/2026 | P | 55,555 | A | $18 | 1,318,983 | I | See Footnote(3) | ||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Series A Preferred Stock | (1) | 02/04/2026 | C(1) | 10,000,000 | (1) | (1) | Common Stock | 1,340,878 | $0.00 | 0 | I | See Footnote(2) | |||
| Series A-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 2,502,252 | (1) | (1) | Common Stock | 335,521 | $0.00 | 0 | I | See Footnote(2) | |||
| Series A-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 5,204,684 | (1) | (1) | Common Stock | 697,885 | $0.00 | 0 | I | See Footnote(3) | |||
| Series A-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 2,602,342 | (1) | (1) | Common Stock | 348,942 | $0.00 | 0 | I | See Footnote(4) | |||
| Series B-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 282,317 | (1) | (1) | Common Stock | 37,855 | $0.00 | 0 | I | See Footnote(2) | |||
| Series B-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 282,317 | (1) | (1) | Common Stock | 37,855 | $0.00 | 0 | I | See Footnote(3) | |||
| Series B-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 282,317 | (1) | (1) | Common Stock | 37,855 | $0.00 | 0 | I | See Footnote(4) | |||
| Series B-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 3,048,192 | (1) | (1) | Common Stock | 408,725 | $0.00 | 0 | I | See Footnote(5) | |||
| Series C Preferred Stock | (1) | 02/04/2026 | C(1) | 12,123 | (1) | (1) | Common Stock | 1,626 | $0.00 | 0 | I | See Footnote(3) | |||
| Series C Preferred Stock | (1) | 02/04/2026 | C(1) | 6,878 | (1) | (1) | Common Stock | 922 | $0.00 | 0 | I | See Footnote(4) | |||
| Series C-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 501,219 | (1) | (1) | Common Stock | 67,207 | $0.00 | 0 | I | See Footnote(3) | |||
| Series C-1 Preferred Stock | (1) | 02/04/2026 | C(1) | 284,392 | (1) | (1) | Common Stock | 38,133 | $0.00 | 0 | I | See Footnote(4) | |||
| Series D Preferred Stock | (1) | 02/04/2026 | C(1) | 1,711,025 | (1) | (1) | Common Stock | 229,428 | $0.00 | 0 | I | See Footnote(2) | |||
| Series D Preferred Stock | (1) | 02/04/2026 | C(1) | 3,422,051 | (1) | (1) | Common Stock | 458,855 | $0.00 | 0 | I | See Footnote(3) | |||
| Warrants | $43.59 | 02/14/2025 | 02/14/2030 | Common Stock | 17,092 | 17,092 | I | See Footnote(2) | |||||||
| Warrants | $43.59 | 02/14/2025 | 02/14/2030 | Common Stock | 34,185 | 34,185 | I | See Footnote(3) | |||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
| Explanation of Responses: |
| 1. Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date. |
| 2. The shares are held of record by Foresite Capital Fund IV, L.P. ("Fund IV"). Foresite Capital Management IV, LLC ("FCM IV") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities. |
| 3. The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities. |
| 4. The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities. |
| 5. The shares are held of record by Foresite Capital VI-A, LLC ("Fund VI-A"). Foresite Capital VI-A Management, LLC ("FC VI-A Management") is the general partner of Fund VI-A and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FC VI-A Management, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI-A, disclaims beneficial ownership of the shares held by Fund VI-A, except to the extent of such person's pecuniary interest in such securities. |
| FORESITE CAPITAL MANAGEMENT IV, LLC, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL FUND IV, L.P., By: Foresite Capital Management IV, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL MANAGEMENT V, LLC, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL FUND V, L.P., By: Foresite Capital Management V, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL OPPORTUNITY MANAGEMENT V, LLC, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL OPPORTUNITY FUND V, L.P., By: Foresite Capital Opportunity Management V, LLC, Its: General Partner, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL VI-A MANAGEMENT, LLC, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| FORESITE CAPITAL VI-A, LLC, By: Foresite Capital VI-A Management, LLC, Its: Managing Member, By: /s/ James B. Tananbaum, Managing Member | 02/06/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||